KDV-B.ST KDventures AB ser. B
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is KDV-B.ST undervalued?
Graham numberThe Graham number of KDventures AB ser. B cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KDventures AB ser. B fundamental analysis
No fundamental analysis for KDventures AB ser. B yet.
KDventures AB ser. B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KDventures AB ser. B
KDventures AB, formerly known as Karolinska Development AB (publ), is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, innovative drug development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in …
Full company profileFinancial statements of KDventures AB ser. B are not available yet.
KDventures AB ser. B dividends
KDventures AB ser. B has not paid dividends in the last 4 fiscal years.
Who owns KDventures AB ser. B
- Insiders 47.22%
- Institutions 16.58%
- Public & others 36.20%
- Free float 451M
KDventures AB ser. B company profile
- Company name
- KDventures AB ser. B
- Ticker
- KDV-B.ST
- Exchange
- Stockholm Exchange
- Sector
- -
- Industry
- -
- Employees
- 7
- Fiscal year end
- December
- Address
- Nanna Svartz väg 6A, Solna, Sweden, 17165
- Phone
- 46 8 52 48 60 70
- Website
- karolinskadevelopment.com
About KDventures AB ser. B
KDventures AB, formerly known as Karolinska Development AB (publ), is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, innovative drug development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. KDventures AB was founded in 2003 and is based in Solna, Sweden with an additional office in Solna Sweden.
KDventures AB ser. B management
7- Dr. Viktor Drvota M.D., Ph.D.Chief Executive Officer · born 1965
- Mr. Hans Christopher TollChief Financial Officer · born 1968
- Ms. Eva MontgomerieHead of Accounting · born 1958
- Mr. Johan DighedGeneral Counsel & Deputy CEO · born 1973
- Mr. Tse PingSenior Strategic Advisor · born 1952
- Dr. John Öhd M.D., Ph.D.Senior Advisor & Venture Partner · born 1971
- Mr. Mathias FrenzelInvestment Analyst · born 1998